Agonist-induced up-regulation of α4β2 nicotinic acetylcholine receptors in M10 cells: Pharmacological and spatial definition

Molecular Pharmacology

Volumn 53, Issue 5, 1998, Pages 950-962

  Whiteaker, Paul ^a,b   Sharples, Christopher G V ^a   Wonnacott, Susan ^a  

^a University of Bath   (United Kingdom)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYL 5 (1 METHYL 2 PYRROLIDINYL)ISOXAZOLE; DECAMETHONIUM; DIHYDRO BETA ERYTHROIDINE; EPIBATIDINE; HEXAMETHONIUM; MECAMYLAMINE; METHYLCARBACHOL; NICOTINIC AGENT; RECEPTOR SUBUNIT; TETRAMETHYLAMMONIUM; TUBOCURARINE CHLORIDE;

ANIMAL CELL; ARTICLE; CELL LINE; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DRUG POTENCY; DRUG RECEPTOR BINDING; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; RECEPTOR AFFINITY; RECEPTOR UPREGULATION;

BICYCLO COMPOUNDS, HETEROCYCLIC; BINDING SITES; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; KINETICS; NICOTINIC AGONISTS; NICOTINIC ANTAGONISTS; PYRIDINES; RECEPTORS, NICOTINIC; TRITIUM; UP-REGULATION;

EID: 0031780511     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Abdulla FA, Bradbury E, Calaminici MR, Lippiello PM, Wonnacott S, Gray JA, and Sinden JD (1996) Relationship between upregulation of nicotine binding sites in rat brain and delayed cognitive enhancement observed after chronic or acute nicotinic receptor stimulation. Psychopharmacology 214:323-331.
2. Alkondon, M and Albuquerque EX (1995) Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons. III. Agonist actions of the novel alkaloid epibatidine and analysis of type II current. J Pharmacol Exp Ther 274:771-782.
3. Barrantes GE, Rogers AT, Lindstrom J, and Wonnacott S (1995) α-Bungarotoxin binding sites in rat hippocampal and cortical cultures: initial characterisation, colocalisation with α7 subunits and up-regulation by chronic nicotine treatment. Brain Res 672:228-236.
4. Bencherif M, Fowler K, Lukas RJ, and Lippiello PM (1995) Mechanisms of upregulation of neuronal nicotinic acetylcholine receptors in clonal cell lines and primary cultures of fetal rat brain. J Pharmacol Exp Ther 275:987-994.
5. Bertrand D, Ballivet M, and Rungger D (1990) Activation and blocking of neuronal nicotinic acetylcholine receptor reconstituted in Xenopus oocytes. Proc Natl Acad Sci USA 87:1993-1997.
6. 3H]nicotine binding in human postmortem brain. J Pharmacol Exp Ther 282:7-13.
7. 50) of an enzymatic reaction. Biochem Pharmacol 22:3099-3108.
8. Conroy WG and Berg DK (1995) Neurons can maintain multiple classes of nicotinic acetylcholine receptor distinguished by different subunit compositions. J Biol Chem 270:4424-4431.
9. Court JA, Perry EK, Spurden D, Lloyd S, Gillespie JI, Whiting P, and Barlow R (1994) Comparison of the binding of nicotinic agonists to receptors from human and rat cerebral cortex and from chick brain (α4β2) transfected into mouse fibroblasts with ion channel activity. Brain Res 667:118-122.
10. Creese I and Sibley DR (1981) Receptor adaptions to centrally acting drugs. Annu Rev Pharmacol Toxicol 21:357-391.
11. El-Bizri H and Clarke PBS (1994) Blockade of nicotinic receptor-mediated release of dopamine from striatal synaptosomes by chlorisondamine administered in vivo. Br J Pharmacol 111:414-418.
12. Elgoyhen AB, Johnson DS, Boulter J, Vetter DE, and Heinemann S (1994) Alpha 9: an acetylcholine receptor with novel pharmacological properties expressed in rat cochlear hair cells. Cell 79:705-715.
13. Flores CM, Rogers SW, Pabreza LA, Wolfe BB, and Kellar KJ (1992) A subtype of nicotinic cholinergic receptor in rat brain is composed of α4 and β2 subunits and is upregulated by chronic nicotine treatment. Mol Pharmacol 41:31-37.
14. Gerzanich V, Peng X, Wang F, Wells G, Anand R, Fletcher S, and Lindstrom J (1995) Comparative pharmacology of epibatidine: a potent agonist for neuronal nicotinic acetylcholine receptors. Mol Pharmacol 48:774-782.
15. Gopalakrishnan M, Monteggia LM, Anderson DJ, Molinari EJ, Piattoni-Kaplan M, Donnelly-Roberts D, Arneric SP, and Sullivan JP (1996) Stable expression, pharmacologic properties and regulation of the human neuronal nicotinic acetylcholine α4β2 receptor. J Pharmacol Exp Ther 276:289-297.
16. Gopalakrishnan M, Molinari EJ, and Sullivan JP (1997) Regulation of human α4/β2 neuronal nicotinic acetylcholine receptors by cholinergic channel ligands and second messenger pathways. Mol Pharmacol 52:524-534.
17. 3H]epibatidine binding to nicotinic cholinergic receptors in rat and human brain. Mol Pharmacol 48:280-287.
18. Hrdina PD (1986)General principles of receptor binding, in Neuromethods Series 1, Neurochemistry 4 (Boulton AA, Baker GB, and Hrdina PD, eds), 1-22. Humana Press, Clifton, NJ.
19. Katz B and Thesleff S (1957) A study of the 'desensitisation' produced by acetylcholine at the motor end plate. J Physiol (Lond) 138:63-80
20. 3H]nicotine binding to putative high affinity receptor sites in brain. Mol Pharmacol 31:392-400.
21. Marks MJ, Stitzel JA, and Collins AC (1985) Time course study of the effects of chronic nicotine infusion on drug response and brain receptors. J Pharmacol Exp Ther 235:619-628.
22. Marks MJ, Pauly JR, Gross SD, Deneris ES, Hermans-Borgmeyer G, Heinemann SF, and Collins AC (1992) Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment. J Neurosci 12:2765-2784.
23. + efflux from mouse brain synaptosomes. J Neurochem 63:2125-2135.
24. + efflux from mouse thalamic synaptosomes. J Pharmacol Exp Ther 277:1383-1396.
25. Markwell MAK, Haas SM, Bieber LL, and Tolbert NE (1978) A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem 87:206-210.
26. A receptor α2 and α3 subunit messenger RNAs as well as polypeptide expression in primary cultured cerebral cortical neurons. Mol Brain Res 24:159-165.
27. Nakayama H, Shioda S, Okuda H, Nakashima T, and Nakai Y (1995) Immunocytochemical localization of nicotinic acetylcholine receptor in rat cerebral cortex. Mol Brain Res 32:321-328.
28. Pauly JR, Marks MJ, Gross SD, and Collins AC (1991) An autoradiographic analysis of cholinergic receptors in mouse brain after chronic nicotine treatment. J Pharmacol Exp Ther 258:1127-1136.
29. Pauly JR, Marks MJ, Robinson SF, van de Kamp JL, and Collins AC (1996) Chronic nicotine and mecamylamine treatment increase brain nicotinic receptor binding without changing α4 or β2 mRNA levels. J Pharmacol Exp Ther 278:361-369.
30. Peng X, Gerzanich V, Anand R, Whiting PJ, and Lindstrom J (1994) Nicotine-induced increase in neuronal nicotinic receptors results from a decrease in the rate of receptor turnover. Mol Pharmacol 46:523-530.
31. Peng X, Gerzanich V, Anand R, Wang F, and Lindstrom J (1997) Chronic nicotine treatment up-regulates α3 and α7 acetylcholine receptor subtypes expressed by the human neuroblastoma cell line SH-SY5Y. Mol Pharmacol 51:776-784.
32. Rothhut B, Romano SJ, Vijayaraghavan S, and Berg DK (1996) Post-translational regulation of neuronal acetylcholine receptors stably expressed in a mouse fibroblast cell line. J Neurobiol 29:115-125.
33. Rowell RP and Li M (1997) Dose-response relationship for nicotine-induced upregulation of rat brain nicotinic receptors. J Neurochem 68:1982-1989.
34. Sanderson EM, Drasdo AL, McCrea K, and Wonnacott S (1993) Upregulation of nicotinic receptors following continuous infusion of nicotine is brain-region specific. Brain Res 617:349-352.
35. Sargent PB (1993) The diversity of neuronal nicotinic acetylcholine receptors. Annu Rev Neurosci 16:403-443.
36. 3H]acetylcholine recognition sites in brain by nicotinic cholinergic drugs. J Neurochem 45:427-433.
37. Stolberg J and Berg DK (1987) Neuronal acetylcholine receptors: fate of surface and internal pools in cell culture. J Neurosci 7:1809-1815.
38. Svensson A-L and Nordberg A (1996) Tacrine interacts with an allosteric activator site on α4β2 nAChRs in M10 cells. Neuroreport 7:2201-2205.
39. Thomas P, Stephens M, Wilkie G, Amar M, Lunt GG, Whiting P, Gallagher T, Pereira E, Alkondon M, Albuquerque EX, and Wonnacott S (1993) (+)Anatoxin-a is a potent agonist at neuronal nicotinic acetylcholine receptors. J Neurochem 60:2308-2311.
40. Vibat CRT, Lasalde JA, McNamee MG, and Ochoa ELM (1995) Differential desensitization properties of rat neuronal nicotinic acetylcholine receptor subunit combinations expressed in Xenopus oocytes. Cell Mol Neurobiol 15:411-425.
41. 3H]epibatidine binding sites on cells expressing the α4β2 subtype of neuronal nicotinic acetylcholine receptors. Br J Pharmacol 119:257.
42. Whiting P, Schoepfer R, Lindstrom J, and Priestley T (1991) Structural and pharmacological characterization of the major brain nicotinic acetylcholine receptor subtype stably expressed in mouse fibroblasts. Mol Pharmacol 40:463-472.
43. Wonnacott S (1990) The paradox of nicotinic acetylcholine receptor upregulation by nicotine. Trends Pharmacol Sci 11:216-219.
44. Wonnacott S and Rogers AT (1996) Upregulation of α7 nicotinic acetylcholine receptors in rat hippocampal cultures. Soc Neurosci Abstr 531.6.
45. Zhang X, Gong Z-H, Hellstrom-Lindahl E, and Nordberg A (1994) Regulation of α4β2 nicotinic acetylcholine receptors in M10 cells following treatment with nicotinic agents. Neuroreport 6:313-317.